Response to Letter to the Editor From Virú-Loza and Chávez-Nomberto: "Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort"

Mohamad Maghnie^{1

2}, Michael B Ranke³, Mitchell E Geffner⁴, Elpis Vlachopapadopoulou⁵, Lourdes Ibáñez^{6

7}, Martin Carlsson⁸, Wayne Cutfield⁹, Raoul Rooman¹⁰, Roy Gomez¹¹, Michael P Wajnrajch^{8

12}, Agnès Linglart^{13

14}, Renata Stawerska^{15

16}, Peter E Clayton¹⁷, Feyza Darendeliler¹⁸, Anita C S Hokken-Koelega¹⁹, Reiko Horikawa²⁰, Toshiaki Tanaka²¹, Helmuth-Günther Dörr²², Kerstin Albertsson-Wikland²³, Michel Polak²⁴, Adda Grimberg²⁵

Affiliations

¹ Department of Pediatrics, IRCCS Giannina Gaslini, Genova 16124, Italy.
² Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health - DINOGMI, University of Genova, Genova 16124, Italy.
³ Department of Pediatric Endocrinology, University Children´s Hospital, Tübingen 72076, Germany.
⁴ The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA.
⁵ Department of Endocrinology, Growth and Development, Aglaia Kyriakou Children's Hospital, Athens 11527, Greece.
⁶ Endocrinology, Pediatric Research Institute Sant Joan de Déu, Barcelona 08950, Spain.
⁷ Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid 28029, Spain.
⁸ Rare Disease, Biopharmaceuticals, Pfizer, New York, NY 10017, USA.
⁹ Liggins Institute, University of Auckland, Auckland 1142, New Zealand.
¹⁰ PendoCon, Putte 2580, Belgium.
¹¹ European Medical Affairs, Pfizer, Brussels 1070, Belgium.
¹² Department of Pediatrics, New York University Langone Medical Center, New York, NY 10016, USA.
¹³ Department of Pediatric Endocrinology and Diabetology for Children, AP-HP, Bicêtre Paris Saclay, Le Kremlin Bicêtre 94270, France.
¹⁴ APHP, Reference Center for Rare Disorders of the Calcium and Phosphate Metabolism, Filière OSCAR and Plateforme d'Expertise Maladies Rares Paris-Sud, Bicêtre Paris Saclay Hospital, Le Kremlin Bicêtre 94270, France.
¹⁵ Department of Endocrinology and Metabolic Diseases, Polish Mother's Memorial Hospital-Research Institute, Lodz 93-338, Poland.
¹⁶ Department of Pediatric Endocrinology, Medical University of Lodz, Lodz 93-338, Poland.
¹⁷ Developmental Biology and Medicine, Faculty of Biology Medicine and Health, Manchester NIHR Academic Health Science Centre, University of Manchester, Manchester M13 9PL, UK.
¹⁸ Istanbul University, Istanbul Faculty of Medicine, Pediatric Endocrinology Unit, İstanbul 34452, Turkey.
¹⁹ Pediatrics, Subdivision of Endocrinology, Erasmus University Medical Center, Rotterdam 3015 GD, the Netherlands.
²⁰ Division of Endocrinology and Metabolism, National Center for Child Health and Development, Tokyo 157-8535, Japan.
²¹ Tanaka Growth Clinic, Tokyo 158-0097, Japan.
²² Division of Pediatric Endocrinology, Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander University of Erlangen Nürnberg, Erlangen 91054, Germany.
²³ Department of Physiology/Endocrinology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg 405 30, Sweden.
²⁴ Université de Paris Cité; Hôpital Universitaire Necker Enfants Malades, Paris 75015, France.
²⁵ Division of Pediatric Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

PMID: 36721915
PMCID: PMC10188301
DOI: 10.1210/clinem/dgad055

Editorial

Response to Letter to the Editor From Virú-Loza and Chávez-Nomberto: "Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort"

Mohamad Maghnie et al. J Clin Endocrinol Metab. 2023.

. 2023 May 17;108(6):e356-e357.

doi: 10.1210/clinem/dgad055.

Authors

Affiliations

¹ Department of Pediatrics, IRCCS Giannina Gaslini, Genova 16124, Italy.
² Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health - DINOGMI, University of Genova, Genova 16124, Italy.
³ Department of Pediatric Endocrinology, University Children´s Hospital, Tübingen 72076, Germany.
⁴ The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA.
⁵ Department of Endocrinology, Growth and Development, Aglaia Kyriakou Children's Hospital, Athens 11527, Greece.
⁶ Endocrinology, Pediatric Research Institute Sant Joan de Déu, Barcelona 08950, Spain.
⁷ Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid 28029, Spain.
⁸ Rare Disease, Biopharmaceuticals, Pfizer, New York, NY 10017, USA.
⁹ Liggins Institute, University of Auckland, Auckland 1142, New Zealand.
¹⁰ PendoCon, Putte 2580, Belgium.
¹¹ European Medical Affairs, Pfizer, Brussels 1070, Belgium.
¹² Department of Pediatrics, New York University Langone Medical Center, New York, NY 10016, USA.
¹³ Department of Pediatric Endocrinology and Diabetology for Children, AP-HP, Bicêtre Paris Saclay, Le Kremlin Bicêtre 94270, France.
¹⁴ APHP, Reference Center for Rare Disorders of the Calcium and Phosphate Metabolism, Filière OSCAR and Plateforme d'Expertise Maladies Rares Paris-Sud, Bicêtre Paris Saclay Hospital, Le Kremlin Bicêtre 94270, France.
¹⁵ Department of Endocrinology and Metabolic Diseases, Polish Mother's Memorial Hospital-Research Institute, Lodz 93-338, Poland.
¹⁶ Department of Pediatric Endocrinology, Medical University of Lodz, Lodz 93-338, Poland.
¹⁷ Developmental Biology and Medicine, Faculty of Biology Medicine and Health, Manchester NIHR Academic Health Science Centre, University of Manchester, Manchester M13 9PL, UK.
¹⁸ Istanbul University, Istanbul Faculty of Medicine, Pediatric Endocrinology Unit, İstanbul 34452, Turkey.
¹⁹ Pediatrics, Subdivision of Endocrinology, Erasmus University Medical Center, Rotterdam 3015 GD, the Netherlands.
²⁰ Division of Endocrinology and Metabolism, National Center for Child Health and Development, Tokyo 157-8535, Japan.
²¹ Tanaka Growth Clinic, Tokyo 158-0097, Japan.
²² Division of Pediatric Endocrinology, Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander University of Erlangen Nürnberg, Erlangen 91054, Germany.
²³ Department of Physiology/Endocrinology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg 405 30, Sweden.
²⁴ Université de Paris Cité; Hôpital Universitaire Necker Enfants Malades, Paris 75015, France.
²⁵ Division of Pediatric Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

PMID: 36721915
PMCID: PMC10188301
DOI: 10.1210/clinem/dgad055

No abstract available

PubMed Disclaimer

Comment on

Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort.
Maghnie M, Ranke MB, Geffner ME, Vlachopapadopoulou E, Ibáñez L, Carlsson M, Cutfield W, Rooman R, Gomez R, Wajnrajch MP, Linglart A, Stawerska R, Clayton PE, Darendeliler F, Hokken-Koelega ACS, Horikawa R, Tanaka T, Dörr HG, Albertsson-Wikland K, Polak M, Grimberg A. Maghnie M, et al. J Clin Endocrinol Metab. 2022 Nov 25;107(12):3287-3301. doi: 10.1210/clinem/dgac517. J Clin Endocrinol Metab. 2022. PMID: 36102184 Free PMC article.
Letter to the Editor From Virú-Loza and Chávez-Nomberto: "Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort".
Virú-Loza MA, Chávez-Nomberto RE. Virú-Loza MA, et al. J Clin Endocrinol Metab. 2023 May 17;108(6):e354-e355. doi: 10.1210/clinem/dgad054. J Clin Endocrinol Metab. 2023. PMID: 36719012 No abstract available.

References

1. Maghnie M, Ranke MB, Geffner ME, et al. . Safety and efficacy of pediatric growth hormone therapy: results from the full KIGS cohort. J Clin Endocrinol Metab. 2022;107(12):3287‐3301. - PMC - PubMed
1. Virú-Loza MA, Chávez-Nomberto RE. Letter to the Editor from Virú-Loza and Chávez-Nomberto: “Safety and efficacy of pediatric growth hormone therapy: results from the full KIGS cohort”. J Clin Endocrinol Metab. 2023;108(6):e354‐e355. - PubMed
1. Grimberg A. Cardiovascular disease in former pediatric recipients of growth hormone: another look at growth hormone safety. JAMA Pediatr. 2021;175(2):e205232. - PubMed
1. Abucham J, Boguszewski MCS. From the full KIGS cohort: on safety and efficacy of growth hormone treatment. J Clin Endocrinol Metab. 2023;108(1):e1‐e2. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Response to Letter to the Editor From Virú-Loza and Chávez-Nomberto: "Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort"

Affiliations

Response to Letter to the Editor From Virú-Loza and Chávez-Nomberto: "Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort"

Authors

Affiliations

Comment on

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources